samedan logo
 
 
 
spacer
home > ebr > spring 2003 > maldi-tof - the technique of choice in proteomics
PUBLICATIONS
European Biopharmaceutical Review

MALDI-TOF - The Technique of Choice in Proteomics

Mass spectrometry is now widely viewed as the analytical technique of choice in proteomics. Its popularity has been driven by the high degree of sensitivity it offers and the ability to search data against rapidly expanding protein and expressed sequence tag (EST) databases. The procedure is based on the generation of gaseous ions from analyte molecules, the subsequent separation of these ions according to their mass to charge (m/z) ratio and the detection of these ions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Chris Sutton, Global Business Manager with Kratos Analytical

Dr Chris Sutton is Global Business Manager for MALDI mass spectrometers with Kratos Analytical, part of Shimadzu Biotech. Shimadzu Biotech, a subsidiary of Shimadzu Corporation, is one of the key providers of analytical solutions for life science and drug discovery.

Chris holds global responsibility for MALDI MS business including sales and marketing, applications, engineering and research and development. He is based at the Kratos Analytical facility in Manchester, UK.

spacer
Dr Chris Sutton
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine

Keele, UK and Matfors, Sweden, 30 March 2020: Cobra Biologics (Cobra), an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet (KI), one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic. Partners in the consortium also include Karolinska University Hospital, Public Health Authority (FoHM), IGEA, Adlego AB and Giessen University.
More info >>

White Papers
 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement